KNC Laboratories Co (FRA:7LW) LT-Debt-to-Total-Asset: 0.12 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7LW KNC Laboratories Co Ltd FRA:7LW
81 GF Score
Price €6.30
GF Value €6.31
! 9 Warning Signs
View Full Analysis

What is KNC Laboratories Co LT-Debt-to-Total-Asset?

KNC Laboratories Co FRA:7LW -2.02% 81 LT-Debt-to-Total-Asset is 0.12 as of Mar. 2026. GuruFocus rates FRA:7LW with a GF Score™ of 81/100 and a GF Value™ of €6.31. The stock has 9 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. KNC Laboratories Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.12.

KNC Laboratories Co's long-term debt to total assets ratio increased from Mar. 2025 (0.11) to Mar. 2026 (0.12). It may suggest that KNC Laboratories Co is progressively becoming more dependent on debt to grow their business.

KNC Laboratories Co  (FRA:7LW) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

KNC Laboratories Co LT-Debt-to-Total-Asset Related Terms

KNC Laboratories Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for KNC Laboratories Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KNC Laboratories Co LT-Debt-to-Total-Asset Chart

KNC Laboratories Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.04 0.07 0.11 0.12

KNC Laboratories Co Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.11 0.11 0.12
FRA:7LW
81GF Score
KNC Laboratories Co Ltd FRA:7LW
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KNC Laboratories Co LT-Debt-to-Total-Asset Calculation

KNC Laboratories Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=13.595/117.985
=0.12

KNC Laboratories Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=13.595/117.985
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.12 mean?
KNC Laboratories Co (FRA:7LW) has a LT-Debt-to-Total-Asset of 0.12 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on KNC Laboratories Co and its competitors.
Is KNC Laboratories Co's LT-Debt-to-Total-Asset too high?
KNC Laboratories Co's current LT-Debt-to-Total-Asset is 0.12. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's LT-Debt-to-Total-Asset compare to DOW?
KNC Laboratories Co's LT-Debt-to-Total-Asset of 0.12 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Chemicals company?
A good LT-Debt-to-Total-Asset depends on the Chemicals industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on KNC Laboratories Co and its competitors. KNC Laboratories Co's current LT-Debt-to-Total-Asset is 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current LT-Debt-to-Total-Asset of 0.12. The stock's GF Value™ is €6.31, compared to a current price of €6.30 — trading 0.2% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.12. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current LT-Debt-to-Total-Asset is 0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?

Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued. The current stock price of €6.30 is trading 0.2% below its estimated GF Value™ of €6.31.

Key valuation signals for FRA:7LW:

  • LT-Debt-to-Total-Asset: 0.12
  • GF Value™: €6.31 vs. price of €6.30 (0.2% below fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KNC Laboratories Co Business Description

Other Exchanges 6568:Japan
Address 1-19 Minatojima Minamimachi, 7-chome, Chuo-ku, Kobe, JPN, 101-0035
KNC Laboratories Co Ltd is an organic chemical and biochemical manufacturing company.
81GF Score

Get the complete analysis for FRA:7LW

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.30
Price
€6.31
GF Value